Viactiv Krankenkasse Tender

This announcement serves to conclude drug discount agreements in accordance with § 130a Paragraph 8 SGB V for the active substance(s) mentioned under point II.1.1). It is not about the award of public contracts within the meaning of Directive 2014/24/EU or Sections 97 ff GWB. Any pharmaceutical company can become a contractual partner in accordance with Section 4 (18) AMG. According to the case law of the ECJ, such approval procedures are not necessarily subject to public procurement law, since there is no competition due to the lack of a selection decision. The announcement serves as an invitation to conclude discount agreements with the same applicable and non-dispositive conditions for all contractual partners, including the determination of the discount. The contract is concluded by signing the contract documents and submitting the required declarations, which can be requested from the contact point named under I.3).